P32 NOVEL ASPECTS IN HORMONAL TREATMENT, BIOMARKERS AND PROGNOSTIC FACTORS
Thursday, 27 March, 14.00-15.30, Red Hall 2
QUALITY OF LIFE EFFECTS OF INTERMITTENT AND CONTINUOUS HORMONAL THERAPY BY CYPROTERONE ACETATE (CPA) FOR METASTATIC PROSTATE CANCER

https://doi.org/10.1016/S1569-9056(08)60537-0Get rights and content

References (0)

Cited by (0)

View full text